Zantac’s Original Maker Halts Shipping on Carcinogen Concern

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc, the original branded maker of Zantac, halted global distribution of the popular stomach medicine, adding momentum to actions aimed at stopping access to drugs th...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.